GeneType Announces The Introduction Of Suite Of Genetic Risk Assessment Tests To Canada And New Zealand
Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease and the parent company of geneType™, today announced the introduction of geneType's suite of genetic risk assessment tests to Canada and New Zealand. Dovetailing geneType's recent expansion to the US market under its partnership with health and wellness technology leader Stayhealthy, Inc ("Stayhealthy"), the company is expanding its international presence four-fold in the second quarter of 2024. The geneType risk assessment test distribution in the new territories will be directed by Stayhealthy Canada and Stayhealthy New Zealand, respectively.
The introduction of products to new markets coincides with the company's recent success in the digital transformation strategy and pilot influencer campaign with Creators Entertainment Group (CEGtalent.com), which has generated a 500% increase in week over week sales.